Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data
Authors:
- 21 November 2022
- journal article
- other
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 64 (1) , 1-3
Abstract
Amyloid light chain (AL) amyloidosis is a rare plasma cell disease in which AL protein deposits form throughout the body, with the heart, and kidney being the most commonly affected organs [1,2]. I...Keywords
Funding Information
- Janssen Inc
This publication has 5 references indexed in Scilit:
- Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims dataJournal of Comparative Effectiveness Research, 2018
- Epidemiology of AL amyloidosis: a real-world study using US claims dataBlood Advances, 2018
- Disease burden of systemic light-chain amyloidosis: a systematic literature reviewCurrent Medical Research and Opinion, 2017
- What do I need to know about immunoglobulin light chain (AL) amyloidosis?Blood Reviews, 2012
- Assessing Validity of ICD‐9‐CM and ICD‐10 Administrative Data in Recording Clinical Conditions in a Unique Dually Coded DatabaseHealth Services Research, 2008